Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Targeted inhibition of kinases in cancer therapyStacey J Baker, E Premkumar ReddyGenes & Cancer|May 2, 2013
CDK4: A Key Player in the Cell Cycle, Development, and CancerStacey J Baker, E Premkumar ReddyGenesis (New York, N.Y. : 2000)|March 3, 2010
p89c-Myb is not required for fetal or adult hematopoiesisStacey J Baker, Atul Kumar, E Premkumar ReddyMolecular and Cellular Biology|August 29, 2003
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-MybAtul Kumar, Stacey J Baker, Clement M Lee, et al.Genes & Cancer|March 29, 2011
Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapiesShashidhar S Jatiani, Stacey J Baker, Lewis R Silverman, et al.Oncotarget|April 9, 2019
Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasiaStacey J Baker, Stephen C Cosenza, M V Ramana Reddy, et al.Genes & Cancer|September 2, 2022
CDK4: a master regulator of the cell cycle and its role in cancerStacey J Baker, Poulikos I Poulikakos, Hanna Y Irie, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
A Drosophila model for Costello Syndrome caused by Ras mutation K117RPrashath Karunaraj, Emily Cao, Harnoor Singh, et al.Nature Communications|July 7, 2022
TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesisYuhan Xia, Kazuki Inoue, Yong Du, et al.Proceedings of the National Academy of Sciences of the United States of America|January 29, 2005
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistanceKiranmai Gumireddy, Stacey J Baker, Stephen C Cosenza, et al.Pageof 10